Stimulating cell proliferation through the pharmacologic activation of c-kit

Blood

Volumn 91, Issue 3, 1998, Pages 890-897

  Jin, Liqing ^a   Asano, Haruhiko ^a   Blau, C Anthony ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; TACROLIMUS;

ARTICLE; CELL PROLIFERATION; CELL STIMULATION; DIMERIZATION; DRUG ACTIVATION; GENE TARGETING; GENE TRANSFER; HEMATOPOIETIC CELL; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STEM CELL;

EID: 0032005179     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.3.890.890_890_897     Document Type: Article

References (45)

1. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoisis in cancer patients. Lancet 342:1134, 1993
2. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD-34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
3. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW: Selection of drug-resistant bone marrow cells in vivo after retroviral transter of human MDR1. Science 257:99, 1992
4. Aran JM, Gottesman MM, Pastan I: Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci USA 91:3176, 1994
5. Migita M, Medin JA, Qawliuk R, Jacobson S, Nagle JW, Anderson S, Amiri M, Humphries RK, Karlsson S: Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic verctors. Proc Natl Acad Sci USA 92:12075, 1995
6. Sorrentino BP: Drug resistance gene therapy, in Brenner MK (ed): Gene Transfer: Scientific Advances and Clinical Developments (in press)
7. Blau CA, Peterson K, Drachman JG, Spencer DM: A proliferation switch for genetically modified cells. Proc Natl Acad Sci USA 94:3076, 1997
8. Ihe JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369, 1995
9. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR: Controlling signal transduction with synthetic ligands. Science 262:1019, 1993
10. Spencer DM, Graef I, Austin DJ, Schreiber SL, Crabtree GR: A general strategy for producing conditional alleles of Src-like tyrosine kinases. Proc Natl Acad Sci USA 92:9805, 1995
11. Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR: Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci USA 92:9810, 1995
12. Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL: Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA 93:4604, 1996
13. Spencer DM: Creating conditional mutations in mammals. Trends Genet 12:181, 1996
14. Ho SN, Spencer DM, Schreiber SL, Crabtree GR: Controlling transcription with dimerizing ligands defines a role for activators in reinitiation. Nature 382:822, 1996
15. Spencer DM, Belshaw P, Chen L, Ho SN, Randazzo F, Crabtree GR, Schreiber SL: Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. Curr Biol 6:839, 1996
16. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F, Holt DA, Gilman M: A humanized system for pharmacologic control of gene expression. Nature Med 2:1028, 1996
17. Bodine DM, Seidel NE, Zsebo KM, Orlic D: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
18. Harrison DE, Zsebo KM, Astle CM: Splenic primitive hematopoietic stem cell (PHSC) activity is enhanced by steel factor because of PHSC proliferation. Blood 83:3146, 1994
19. Bodine DM, Seidel NE, Orlic D: Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88:89, 1996
20. Liu J, Farmer JJ, Lane WS, Friedman J, Weissman I, Schreiber SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807, 1991
21. Cross FR, Garber EA, Pellman D, Hanafusa H: A shot sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol Cell Biol 4:183, 1984
22. Standaert RF, Galat A, Verdine GL, Schreiber SL: Molecular cloning and overexpression of the human FK506-binding protein FKBP12. Nature 346:671, 1990
23. Kolodziej PA, Young RA: Epitope tagging and protein surveillance. Methods Enzymol 194:508, 1991
24. Ohashi H, Dameda R, Nishikawa M, Kawagishi M, Liu YC: The c-kit receptor transduces the stem cell factor-triggered growth signal in murine interleukin-3-dependent cell line. Cytotechnology 16:27, 1994
25. Amara JF, Clackson T, Rivera VM, Guo T, Keenan T, Natesan S, Pollock R, Yang W, Courage NL, Holt DA, Gilman M: A versatile synthetic dimerizer for the regulation of protein-protein interactions. Proc Natl Acad Sci USA 94:10618, 1997
26. Browning PJ, Bunn HF, Cline A, Shuman M, Neinhuis AW: "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential. Proc Natl Acad Sci USA 83:7800, 1986
27. Rossel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ: Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 325:549, 1987
28. Blau CA, Neff T, Papayannopoulou Th: The hematological effects of folate analogs: Implications for using the dihydrofolate reductase gene for in vivo selection. Hum Gene Ther 7:2069, 1996
29. Blau CA, Neff T, Papayannopoulou Th: Cytokine prestimulation as a gene therapy strategy: Implications for using the MDR1 gene as a dominant selectable marker. Blood 89:14, 1997
30. Stromhaug A, Warren DJ, Slordal L: Effect of methotrexate on murine bone marrow cells in vitro: Evidence of a reversible antiproliferative action. Exp Hematol 23:439, 1995
31. Stromhaug A, Slordal L, Warren DJ: Differential effects of the antifolates methrotrexate, aminopterin and trimetrexate on murine haemopoietic progenitor cells. Br J Haematol 92:514, 1996
32. Russell E: Hereditary anemias of the mouse: A review for geneticists. Adv Genet 20:357, 1979
33. Chabot B, Stephenson DA, Chapman AM, Besmer P, Bernstein A: The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88, 1988
34. Bernstein S, Russell E: Implantation of normal blood forming tissue in geneticallyanemic mice, without the irradiation of the host. Proc Exp Biol Med 101:769, 1959
35. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisadda T, Sudo T, Kina T, Nakauchi H, Nishikawa SI: Expression and function of c-kit in hemapoietic progenitor cells. J Exp Med 174:63, 1991
36. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
37. Andrews RG, Bartelmez SH, Knitter GH, Myerson D, Bernstein ID, Appelbaum FR, Zsebo KM: A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons. Blood 80:920, 1992
38. Andrews RG, Bensinger WI, Knitter GH, Myerson D, Bernstein ID, Appelbaum FR, Zsebo KM: A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons. Blood 80:920, 1992
39. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790, 1995
40. Tsujimura T, Morimoto M, Hashimoto K, Moriyama Y, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y: Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood 87:273, 1996
41. Herbst R, Munemitsu S, Ullrich A: Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site. Oncogene 10:369, 1995
42. Zsebo DM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino DH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
43. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88:6382, 1991
44. Galli SH, Iemura A, Garlick DS, Gamba VC, Zsebo DM, Andrews RG: Reversible expansion of primate mast cell population in vivo by stem cell factor. J Clin Invest 91:148, 1993
45. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681, 1996